Copyright Reports & Markets. All rights reserved.

Global Cancer Stem Cells Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cancer Stem Cells Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Cell Culturing
      • 1.4.3 Cell Separation
      • 1.4.4 Cell Analysis
      • 1.4.5 Molecular Analysis
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Cancer Stem Cells Market Share by Application (2014-2025)
      • 1.5.2 Breast Cancer Diagnosis and Treatment
      • 1.5.3 Prostate Cancer Diagnosis and Treatment
      • 1.5.4 Colorectal Cancer Diagnosis and Treatment
      • 1.5.5 Lung Cancer Diagnosis and Treatment
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cancer Stem Cells Market Size
    • 2.2 Cancer Stem Cells Growth Trends by Regions
      • 2.2.1 Cancer Stem Cells Market Size by Regions (2014-2025)
      • 2.2.2 Cancer Stem Cells Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Cancer Stem Cells Market Size by Manufacturers
      • 3.1.1 Global Cancer Stem Cells Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Cancer Stem Cells Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Cancer Stem Cells Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cancer Stem Cells Key Players Head office and Area Served
    • 3.3 Key Players Cancer Stem Cells Product/Solution/Service
    • 3.4 Date of Enter into Cancer Stem Cells Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cancer Stem Cells Market Size by Type (2014-2019)
    • 4.2 Global Cancer Stem Cells Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Cancer Stem Cells Market Size (2014-2019)
    • 5.2 Cancer Stem Cells Key Players in United States
    • 5.3 United States Cancer Stem Cells Market Size by Type
    • 5.4 United States Cancer Stem Cells Market Size by Application

    6 Europe

    • 6.1 Europe Cancer Stem Cells Market Size (2014-2019)
    • 6.2 Cancer Stem Cells Key Players in Europe
    • 6.3 Europe Cancer Stem Cells Market Size by Type
    • 6.4 Europe Cancer Stem Cells Market Size by Application

    7 China

    • 7.1 China Cancer Stem Cells Market Size (2014-2019)
    • 7.2 Cancer Stem Cells Key Players in China
    • 7.3 China Cancer Stem Cells Market Size by Type
    • 7.4 China Cancer Stem Cells Market Size by Application

    8 Japan

    • 8.1 Japan Cancer Stem Cells Market Size (2014-2019)
    • 8.2 Cancer Stem Cells Key Players in Japan
    • 8.3 Japan Cancer Stem Cells Market Size by Type
    • 8.4 Japan Cancer Stem Cells Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cancer Stem Cells Market Size (2014-2019)
    • 9.2 Cancer Stem Cells Key Players in Southeast Asia
    • 9.3 Southeast Asia Cancer Stem Cells Market Size by Type
    • 9.4 Southeast Asia Cancer Stem Cells Market Size by Application

    10 India

    • 10.1 India Cancer Stem Cells Market Size (2014-2019)
    • 10.2 Cancer Stem Cells Key Players in India
    • 10.3 India Cancer Stem Cells Market Size by Type
    • 10.4 India Cancer Stem Cells Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cancer Stem Cells Market Size (2014-2019)
    • 11.2 Cancer Stem Cells Key Players in Central & South America
    • 11.3 Central & South America Cancer Stem Cells Market Size by Type
    • 11.4 Central & South America Cancer Stem Cells Market Size by Application

    12 International Players Profiles

    • 12.1 Thermo Fisher Scientific
      • 12.1.1 Thermo Fisher Scientific Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cancer Stem Cells Introduction
      • 12.1.4 Thermo Fisher Scientific Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.1.5 Thermo Fisher Scientific Recent Development
    • 12.2 Abbvie
      • 12.2.1 Abbvie Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cancer Stem Cells Introduction
      • 12.2.4 Abbvie Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.2.5 Abbvie Recent Development
    • 12.3 Merck Kgaa
      • 12.3.1 Merck Kgaa Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cancer Stem Cells Introduction
      • 12.3.4 Merck Kgaa Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.3.5 Merck Kgaa Recent Development
    • 12.4 Bionomics
      • 12.4.1 Bionomics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cancer Stem Cells Introduction
      • 12.4.4 Bionomics Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.4.5 Bionomics Recent Development
    • 12.5 Lonza
      • 12.5.1 Lonza Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cancer Stem Cells Introduction
      • 12.5.4 Lonza Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.5.5 Lonza Recent Development
    • 12.6 Stemline Therapeutics
      • 12.6.1 Stemline Therapeutics Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cancer Stem Cells Introduction
      • 12.6.4 Stemline Therapeutics Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.6.5 Stemline Therapeutics Recent Development
    • 12.7 Miltenyi Biotec
      • 12.7.1 Miltenyi Biotec Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cancer Stem Cells Introduction
      • 12.7.4 Miltenyi Biotec Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.7.5 Miltenyi Biotec Recent Development
    • 12.8 Promocell
      • 12.8.1 Promocell Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Cancer Stem Cells Introduction
      • 12.8.4 Promocell Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.8.5 Promocell Recent Development
    • 12.9 Macrogenics
      • 12.9.1 Macrogenics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Cancer Stem Cells Introduction
      • 12.9.4 Macrogenics Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.9.5 Macrogenics Recent Development
    • 12.10 Oncomed Pharmaceuticals
      • 12.10.1 Oncomed Pharmaceuticals Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Cancer Stem Cells Introduction
      • 12.10.4 Oncomed Pharmaceuticals Revenue in Cancer Stem Cells Business (2014-2019)
      • 12.10.5 Oncomed Pharmaceuticals Recent Development
    • 12.11 Irvine Scientific
    • 12.12 Stemcell Technologies
    • 12.13 Sino Biological
    • 12.14 Biotime

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
      Over the past few years, stem cells are being successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development or after tumor treatment.
      In 2018, the global Cancer Stem Cells market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Cancer Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Stem Cells development in United States, Europe and China.

      The key players covered in this study
      Thermo Fisher Scientific
      Abbvie
      Merck Kgaa
      Bionomics
      Lonza
      Stemline Therapeutics
      Miltenyi Biotec
      Promocell
      Macrogenics
      Oncomed Pharmaceuticals
      Irvine Scientific
      Stemcell Technologies
      Sino Biological
      Biotime

      Market segment by Type, the product can be split into
      Cell Culturing
      Cell Separation
      Cell Analysis
      Molecular Analysis
      Others

      Market segment by Application, split into
      Breast Cancer Diagnosis and Treatment
      Prostate Cancer Diagnosis and Treatment
      Colorectal Cancer Diagnosis and Treatment
      Lung Cancer Diagnosis and Treatment
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cancer Stem Cells status, future forecast, growth opportunity, key market and key players.
      To present the Cancer Stem Cells development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cancer Stem Cells are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now